9 completed, 1 active not recruiting, 1 terminated, 1 unknown. 6 Phase 2, 3 Not applicable, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 6 |
| Not applicable | 3 | Active not recruiting 1, Terminated 1, Unknown 1 |
| Phase 1 | 3 | Completed 3 |
Follow Scar Prevention: new trials by email Literature Review of Scar Prevention trials Research Report on Scar Prevention
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mepiform in Simultaneous Bilateral TKA Silicone dressing - Scar Prevention | Not applicable | Active not recruiting | Thammasat University Hospital | 30 | 2024-03-07 | 2025-04-09 |
| A Study of Single Ascending Dose of LEM-S401 in Healthy Participants LEM-S401, Placebo - Cicatrix, Scar Prevention | Phase 1 | Completed | Lemonex Inc. | 19 | 2022-07-11 | 2023-02-16 |
| Combined Intense Pulsed Light (IPL) With Fractional Erbium:YAG Laser Ablation in Scar Prevention fractional Er:YAG laser, Intense pulse light - Intense Pulsed Light, Erbium-yttrium Aluminum Garnet Laser | Not applicable | Unknown | Hallym University Kangnam Sacred Heart Hospital | 30 | 2020-01-06 | 2021-01-26 |
| Scar Prevention Using Fractional Carbon Dioxide Laser Treatment Lumenis UltraPulse single fractional CO2 laser treatment thin skin, Single fractional CO2 treatment at surgical area closure procedure on thick skin - Scar Prevention | Not applicable | Terminated | Lumenis Be Ltd. | 10 | 2013-01-01 | 2014-03-26 |
| Evaluation of Safety, PK, and Preliminary Effects on Scar Formation of Multiple Intradermal Administrations of RXI-109 RXI-109, Placebo - Cicatrix, Scar Prevention | Phase 1 | Completed | RXi Pharmaceuticals, Corp. | 15 | 2012-12-01 | 2014-12-03 |
| Evaluation of the Safety, Pharmacokinetics, and Preliminary Effect on Scar Formation by RXI-109 RXI-109, Placebo - Cicatrix, Scar Prevention | Phase 1 | Completed | RXi Pharmaceuticals, Corp. | 15 | 2012-06-01 | 2014-09-17 |
| Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery EXC 001, Placebo - Scar Prevention | Phase 2 | Completed | Pfizer | 25 | 2009-12-22 | 2021-08-02 |
| Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty EXC 001, Placebo - Scar Prevention | Phase 2 | Completed | Pfizer | 41 | 2009-12-03 | 2021-08-02 |
| Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty EXC 001, Placebo - Scar Prevention | Phase 2 | Completed | Pfizer | 30 | 2009-12-01 | 2021-09-20 |
| A Study to Evaluate the Safety and Efficacy of Additional Doses of AZX100 Drug Product Following Excision of Keloid Scars AZX100 Drug Product, Placebo - Scar Prevention, Scar Reduction | Phase 2 | Completed | Capstone Therapeutics | 59 | 2009-05-01 | 2012-10-11 |
| A Study to Evaluate the Safety and Efficacy of AZX100 Drug Product Following Excision of Keloid Scars AZX100 Drug Product, Placebo - Scar Prevention, Scar Reduction | Phase 2 | Completed | Capstone Therapeutics | 59 | 2009-03-01 | 2012-10-11 |
| A Phase 2a Study to Evaluate the Safety and Efficacy of AZX100 in Trocar Sites of Arthroscopic Shoulder Surgery Patients Placebo, AZX100 - Scar Prevention, Scar Reduction | Phase 2 | Completed | Capstone Therapeutics | 150 | 2009-01-01 | 2012-10-11 |
Cicatrix (9) · Fibrosis (5) · Keloid (2) · Pathologic Processes (2)
Pathological Conditions, Signs and Symptoms (9) · Pathologic Processes (7) · Fibrosis (4) · Collagen Diseases (2) · Connective Tissue Diseases (2) · Skin and Connective Tissue Diseases (2)
AZX 100 (1)
Capstone Therapeutics (3) · Pfizer (3) · RXi Pharmaceuticals, Corp. (2) · Hallym University Kangnam Sacred Heart Hospital (1) · Lemonex Inc. (1) · Lumenis Be Ltd. (1) · Thammasat University Hospital (1)
United States (8) · South Korea (2) · Thailand (1)
Bo Young Chung, M.D., PhD (1) · Yot Tanariyakul, M.D. (1)